DK180288A - 5-substituerede quinolon- og naphthyridoncarboxylsyrederivater, deres fremstilling og anvendelse - Google Patents
5-substituerede quinolon- og naphthyridoncarboxylsyrederivater, deres fremstilling og anvendelseInfo
- Publication number
- DK180288A DK180288A DK180288A DK180288A DK180288A DK 180288 A DK180288 A DK 180288A DK 180288 A DK180288 A DK 180288A DK 180288 A DK180288 A DK 180288A DK 180288 A DK180288 A DK 180288A
- Authority
- DK
- Denmark
- Prior art keywords
- quinolon
- substituted
- preparation
- acid derivatives
- naphthyridoncarboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873711193 DE3711193A1 (de) | 1987-04-02 | 1987-04-02 | 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK180288D0 DK180288D0 (da) | 1988-03-30 |
| DK180288A true DK180288A (da) | 1988-10-03 |
Family
ID=6324762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK180288A DK180288A (da) | 1987-04-02 | 1988-03-30 | 5-substituerede quinolon- og naphthyridoncarboxylsyrederivater, deres fremstilling og anvendelse |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0284935A1 (pt) |
| JP (1) | JPS63258855A (pt) |
| KR (1) | KR880012593A (pt) |
| CN (1) | CN88101741A (pt) |
| AU (1) | AU1381188A (pt) |
| DD (1) | DD274029A5 (pt) |
| DE (1) | DE3711193A1 (pt) |
| DK (1) | DK180288A (pt) |
| FI (1) | FI881501A (pt) |
| HU (1) | HU201050B (pt) |
| IL (1) | IL85943A0 (pt) |
| NO (1) | NO881121L (pt) |
| PT (1) | PT87124B (pt) |
| ZA (1) | ZA882318B (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591744A (en) * | 1987-04-16 | 1997-01-07 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| JPS649992A (en) * | 1987-06-30 | 1989-01-13 | Dainippon Pharmaceutical Co | 1,8-crosslinked quinolincarboxylic acid derivative, ester thereof and salt thereof |
| US4839355A (en) * | 1987-09-09 | 1989-06-13 | Sterling Drug Inc. | Tricyclic-pyridinylquinoline compounds, their preparation and use |
| US5164392A (en) * | 1987-10-16 | 1992-11-17 | Dainippon Pharmaceutical Co., Ltd. | Quinoline derivatives and antibacterial agent containing them |
| IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
| JPH0228178A (ja) * | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法 |
| AU609974B2 (en) * | 1988-05-18 | 1991-05-09 | Warner-Lambert Company | Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids |
| JPH0674261B2 (ja) * | 1988-06-21 | 1994-09-21 | 塩野義製薬株式会社 | キノロンカルボン酸誘導体 |
| FI901201A0 (fi) * | 1989-03-13 | 1990-03-09 | Bristol Myers Squibb Co | Antibakteriella 5-substituerade 1,4-dihydro-4-oxonaftyridin-3-karboxylatderivat och deras framstaellning. |
| EP0489733A1 (en) * | 1989-04-26 | 1992-06-17 | The Upjohn Company | Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents |
| US5385913A (en) * | 1989-10-06 | 1995-01-31 | Pfizer Inc. | 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents |
| WO1991004972A1 (en) * | 1989-10-06 | 1991-04-18 | Pfizer Inc. | 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents |
| CA2078444A1 (en) | 1990-04-18 | 1991-10-19 | Thomas P. Demuth, Jr. | Antimicrobial quinolonyl lactams |
| DE4032560A1 (de) * | 1990-10-13 | 1992-04-16 | Bayer Ag | 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate |
| FR2681863B1 (fr) * | 1991-09-27 | 1995-02-03 | Rhone Dpc Europ | Solution de sparfloxacine sa preparation et sel la constituant. |
| WO1993013101A1 (en) * | 1991-12-27 | 1993-07-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound |
| US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| TW252107B (pt) * | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
| EP0806421A4 (en) * | 1995-01-24 | 1998-04-15 | Hokuriku Pharmaceutical | DERIVATIVES OF CHINOLINE CARBONIC ACID |
| DE10108750A1 (de) * | 2001-02-23 | 2002-09-05 | Bayer Ag | Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren |
| JP2006504690A (ja) * | 2002-09-10 | 2006-02-09 | ファイザー・プロダクツ・インク | Ｃｎｓ及びその他の障害の治療に有用なジアザ二環式化合物 |
| KR101077755B1 (ko) | 2003-09-10 | 2011-10-27 | 교린 세이야꾸 가부시키 가이샤 | 7-(4-치환-3-시클로프로필아미노메틸-1-피롤리디닐)퀴놀론카르본산 유도체 |
| EP2522670A1 (en) | 2004-04-07 | 2012-11-14 | Takeda Pharmaceutical Company Limited | Heterocyclic CRF receptor antagonists |
| JP5322927B2 (ja) | 2007-05-24 | 2013-10-23 | 杏林製薬株式会社 | １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体 |
| CN105037388A (zh) * | 2015-08-28 | 2015-11-11 | 安徽环球药业股份有限公司 | 一种安妥沙星的制备方法 |
| CN106674254B (zh) * | 2016-12-21 | 2019-03-15 | 广东省中医院 | 一类喹诺酮羧酸化合物及其中间体、制备方法以及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59137482A (ja) * | 1983-01-26 | 1984-08-07 | Otsuka Pharmaceut Co Ltd | ピロロ〔３，２，１，−ｉｊ〕キノリン−５−カルボン酸誘導体 |
| IE58742B1 (en) * | 1984-07-20 | 1993-11-05 | Warner Lambert Co | Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds |
| US4657913A (en) * | 1985-04-18 | 1987-04-14 | Warner-Lambert Company | Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents |
| AU594983B2 (en) * | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
| US4977154A (en) * | 1985-12-12 | 1990-12-11 | Warner-Lambert Company | 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents |
| EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
-
1987
- 1987-04-02 DE DE19873711193 patent/DE3711193A1/de not_active Withdrawn
-
1988
- 1988-03-14 NO NO881121A patent/NO881121L/no unknown
- 1988-03-21 EP EP88104452A patent/EP0284935A1/de not_active Withdrawn
- 1988-03-28 AU AU13811/88A patent/AU1381188A/en not_active Abandoned
- 1988-03-29 DD DD88314159A patent/DD274029A5/de not_active IP Right Cessation
- 1988-03-30 FI FI881501A patent/FI881501A/fi not_active Application Discontinuation
- 1988-03-30 PT PT87124A patent/PT87124B/pt not_active IP Right Cessation
- 1988-03-30 DK DK180288A patent/DK180288A/da not_active Application Discontinuation
- 1988-03-31 CN CN198888101741A patent/CN88101741A/zh active Pending
- 1988-03-31 ZA ZA882318A patent/ZA882318B/xx unknown
- 1988-03-31 IL IL85943A patent/IL85943A0/xx unknown
- 1988-03-31 KR KR1019880003588A patent/KR880012593A/ko not_active Application Discontinuation
- 1988-04-01 JP JP63078298A patent/JPS63258855A/ja active Pending
- 1988-04-01 HU HU881619A patent/HU201050B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT87124B (pt) | 1992-07-31 |
| AU1381188A (en) | 1988-10-06 |
| HU201050B (en) | 1990-09-28 |
| NO881121L (no) | 1988-10-03 |
| IL85943A0 (en) | 1988-09-30 |
| DD274029A5 (de) | 1989-12-06 |
| KR880012593A (ko) | 1988-11-28 |
| PT87124A (pt) | 1988-04-01 |
| ZA882318B (en) | 1988-10-04 |
| JPS63258855A (ja) | 1988-10-26 |
| HUT47098A (en) | 1989-01-30 |
| DE3711193A1 (de) | 1988-10-13 |
| DK180288D0 (da) | 1988-03-30 |
| FI881501A (fi) | 1988-10-03 |
| FI881501A0 (fi) | 1988-03-30 |
| EP0284935A1 (de) | 1988-10-05 |
| CN88101741A (zh) | 1988-11-16 |
| NO881121D0 (no) | 1988-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK180288A (da) | 5-substituerede quinolon- og naphthyridoncarboxylsyrederivater, deres fremstilling og anvendelse | |
| DK157488A (da) | Substituerede triazolinoner, deres fremstilling og anvendelse | |
| NO882390L (no) | (ih-azol-1-ylmetyl)substituerte benzotriazolderivater og deres fremstilling. | |
| DK374289D0 (da) | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse | |
| DK605489A (da) | Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse | |
| NO892745D0 (no) | Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling. | |
| NO871526L (no) | Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling. | |
| DK595388A (da) | Benzopyranderivater, deres fremstilling og anvendelse | |
| DK193088D0 (da) | 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse | |
| DK335286D0 (da) | 5-substituerede 6-aminopyrimidinderivater, deres fremstilling og anvendelse | |
| DK278188D0 (da) | Thiazolidin-4-on-derivater, deres fremstilling og anvendelse | |
| DK189488A (da) | Imidazothiadiazinderivater, deres fremstilling og anvendelse | |
| DK213387D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK162087D0 (da) | Piperidinforbindelser, deres fremstilling og anvendelse | |
| DK212687D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK223288A (da) | Benzensulfornamid-derivater, deres fremstilling og anvendelse | |
| DK610787D0 (da) | Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse | |
| DK412188A (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK231988A (da) | 2-aminoalkyl-4-benzyl-1-(2h)-phthalazinon-derivater, deres fremstilling og anvendelse | |
| NO885020D0 (no) | Isokinolinderivater, deres fremstilling og anvendelse. | |
| DK613888D0 (da) | Acyllabdan-derivater, deres fremstilling og anvendelse | |
| DK361388D0 (da) | Cephemderivater, deres fremstilling og anvendelse | |
| DK668888A (da) | Labdan-derivater, deres fremstilling og anvendelse | |
| DK668788D0 (da) | Labdanderivater, deres fremstilling og anvendelse | |
| DK727388D0 (da) | 2-aminotetrahydroisoquinolinderivater, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |